Department of Obstetrics and Gynecology, Women and Infant's Hospital, Providence, Rhode Island; Warren Alpert Medical School, Brown University, Providence, Rhode Island.
Department of Obstetrics and Gynecology, Women and Infant's Hospital, Providence, Rhode Island; Warren Alpert Medical School, Brown University, Providence, Rhode Island.
J Minim Invasive Gynecol. 2018 Feb;25(2):287-296. doi: 10.1016/j.jmig.2017.07.008. Epub 2017 Jul 20.
Ectopic pregnancies account for 1.5% to 2% of all pregnancy in the United States. Of these, approximately 10% implant in nontubal locations, including the abdominal cavity, cervix, ovary, interstitial portion of the fallopian tube, broad ligament, the uterine cornua, or within a cesarean section scar. Because these pregnancies tend to present later than typical tubal pregnancies, they have been associated with greater maternal morbidity and mortality. Advances in ultrasound technology have allowed for earlier diagnosis of nontubal ectopic pregnancies, which in turn has led to the development of novel minimally invasive techniques to manage them. One of these methods involves the local injection of 1 of several agents directly into the ectopic pregnancy. In this article we provide a guide to this technique of local injection, including an overview of the potential agents that can be used, and review the diagnostic and specific ultrasound criteria, other possible treatment options, and overall outcomes for nontubal ectopic pregnancies.
在美国,异位妊娠占所有妊娠的 1.5%至 2%。其中,约 10%在非输卵管部位着床,包括腹腔、宫颈、卵巢、输卵管间质部、阔韧带、子宫角或剖宫产瘢痕内。由于这些妊娠往往比典型的输卵管妊娠出现得更晚,因此与更大的母亲发病率和死亡率相关。超声技术的进步使得能够更早地诊断非输卵管异位妊娠,这反过来又导致了开发新的微创技术来治疗它们。其中一种方法涉及将几种药物中的一种直接注射到异位妊娠部位。本文提供了这种局部注射技术的指南,包括可使用的潜在药物概述,并回顾了非输卵管异位妊娠的诊断和特定超声标准、其他可能的治疗选择以及总体结果。